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ENCEPHALITIS FOLLOWING MODIFIED MEASLES
A.

ROBERT BAUER,

M.D.

AND PHILIP J. HOWARD,

M.D.

In 1958 Riley 1 reported two cases of encephalitis following measles that had
been modified by prophylactic injections of gamma globulin. He also referred to the
reports of three previous authentic cases and to twelve possible cases which were
not documented. The purpose of this communication is to report two additional
cases, consider any pertinent information which might clarify the unexpected occurrence
of encephalitis following modified measles and to discuss the relation of this circum
stance to the current use of measles vaccine.
REPORT OF CASES

CASE 1 was a white male of four years and two months who was exposed to measles
by his nine-year-old brother on April 10, 1963. On the basis of history this was established
as the first day of contact. On April 15, 1963 he was given 0.9 ml (0.045 ml/Kg) of gamma
globulin. On April 26, 1963 he complained that he did not feel good, became anorexic and
vomited but was afebrile. On May l, 1963 his eyes became red and he developed a few
spots on his face. Cough was conspicuously absent but he did sneeze a few times. Physical
examination on that day revealed a few red macules on the face and body, slight redness
of the conjunctiva, moderate redness of the throat and a single white spot on the buccal
mucous membrane. Oral temperature was 101.6F. Treatment consisted of sulfisoxazole 1.5
gm q 4 hours for two days. The temperature reached normal the following day and he had
no further symptoms. At 7 a.m. on May 6, 1963 he got out of bed to go to the bath room,
where he fell to the floor and was unable to get up. The parents reported that "his right
side was involved but there was no shaking and he had a gurgle in his throat". He was
taken to the emergency room of a nearby hospital where he received an injection and a
suppository of phenobarbitol after which he seemed better. He was then admitted to this
hospital.
Physical Examination: There was a positive Kernig's sign and minimal nuchal rigidity
and a normal plantar reflex. The fundi were normal. The color was dusky and there was
a fading rash noted on the face and chest. His sensorium was cloudy as evidenced by a
lack of his usual sharpness in comprehending situations and interest in co-operating. He
talked irrationally and was extremely irritable. His refusal to allow examination represented
a marked change in personality. Temperature was 39.5 ° C. The remainder of the physical
examination was negative. The admission spinal tap gave normal hydrodynamics.
Laboratory Findings: Spinal fluid WBC'c 33 (Polys 9, Monos 24),
61 mg per cent, Glucose 50 mg per cent, negative culture. Blood count:
7,000, N 44, L 55, M 1. Blood Calcium 10.6 mg per cent, Phosphorus
Blood Glucose 79 mg per cent. Skull X-ray was negative. An EEG done
reported - "evidence of a severe diffuse cerebral disturbance throughout
with peaks that suggest brain stem involvement". Urine was negative.

RBC's 3, Protein
Hb 12.5 g, WBC
3.3 mg per cent,
on May 8, 1963
both hemispheres

Course: Phenobarbitol was given to the patient in the afternoon of the admission day
to control the irritability, but it stimulated him instead. He was then given diphenhydramine
hydrochloride which did sedate him. At 10 p.m. that day he talked coherently but was still
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irritable. The next two days the nuchal rigidity was Jess and the temperature gradually
subsided to normal. There was little other change. On May 9, 1963 the nuchal rigidity
returned to the original degree, Kernig's sign and Brudzinski's sign were positive and tbe
cremasteric and abdominal reflexes were absent. The deep tendon reflexes were not obtained.
On May 10, 1963 the nucbal rigidity was again Jess and the deep tendon reflexes were obtained.
On :May 13, 1963 he had improved considerably - his personality had returned to normal.
The cremasteric and abdominal reflexes had returned, and there was only slight nuchal
resistance to flexion. There was no neurological deficit. On May 15, 1963 he was discharged
from the hospital in good condition.
Follow Up: A repeat EEG was made on June 27, 1963 which was reported as "normal
for age". He was seen in the office July 7, 1963 at which time his mental condition was
felt to be normal and there were no neurological signs. All deep and superficial reflexes
were obtained normally. He was seen on several occasions for respiratory infections without
any evidence of neurological or mental residuals. At the time of his last visit, January 4,
1964 he was still normal in every way.

*

*
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CASE 2 was a three-year-old white female. History revealed that she was exposed to
measles by an older sister on May 13, 1963. On May 16, 1963 she was given 0.4 ml of
gamma globulin (Wt. 16.3 Kg). She was reported as being febrile off and on since May 20,
1963. A rash appeared back of the ears on May 24, 1963 and became general on May 28,
1953, at which time she "had a high fever". There was no cough. On June 3, 1963 she
was drowsy for four hours in the morning, and after a deep sleep lasting one hour, she
woke up vomiting. Her physician considered that she had a convulsion and referred her
to this hospital.
Physical Examination: Patient was a well nourished white girl of about 16.3 Kg with
a generalized severe macular rash. Her color was cyanotic. There was twitching of the left
side of the mouth and the eyes deviated to the left. Her convulsive state persisted with
twitching of the right thumb, arm, shoulder and right leg until controlled with IV sedation
(Sodium Amytol 60 mg). Her sensorium was depressed to unconsciousness from the time
of the convulsion until three hours later when she cried with painful stimuli. This gradually
improved, and an hour later she called to her mother. At 2 a.m. next day her sensorium
cleared and she talked coherently. Ao admission spinal tap gave normal hydrodynamics.
Laboratory findings: Blood count - Hb 10.5 g, WBC's 17,700, N 79, L 15, E 1 and
M 5. Urine was normal. Spinal fluid - WBC's 21, Polys 12, Monos 9, Protein 47 mg per
cent, Glucose 75 mg per cent. Ao EEG made June 6, 1963 showed evidence of cerebral
disturbance in the left occipital parietal region.
Course: Treatment was carried out with intravenous fluids, sedation and hydrocortisone.
A satisfactory recovery followed and she left the hospital June 8, 1963. A repeat EEG made
on June 20, 1963 gave evidence of a moderate somewhat paroxysmal disturbance in the left
temporal and posterior regions. This represented an increase in paroxysmal character from
the first examination. A report from her personal physician indicates that up to the time
of this report the patient is completely normal. Documentation of diagnosis in both cases
is based on criteria of Tyler.2

COMMENT
We believe that the occurrence of measles encephalitis in patients whose measles
was modified by gamma globulin assumes new significance because of the widespread
interest in and use of measles vaccine to prevent or modify measles through active
immunization. Fulginiti and Kempe 2 reported on 5,000 children who had received
measles vaccine. Of this number, 632 were subsequently known to have been exposed
to measles. Of these, 39 or 6.3 per cent developed unmodified measles, 73 or 11.5
per cent developed modified measles and 520, or 82.2 per cent did not develop
recognizable measles. Their figures also indicate that the best immunization was
obtained from the use of two injections of inactivated virus, followed by one injection
of live virus, giving 87 per cent complete protection (no measles) 13 per cent partial
protection (modified measles) and no case of unmodified measles.
202
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matter of great importance in preventing encephalitis, as will be pointed out later,
since the other two systems of immunization (one injection of live virus together
with gamma globulin or three injections of inactivated virus) were both followed
by a significant number of unmodified cases and more modified cases.
It is not unreasonable to assume that the immunity obtained from the administra
tion of gamma globulin is similar to that produced actively by means of measles
vaccine. In fact, Fulginiti and Kempe3 state that:
"The measles neutralizing antibody contained in pooled adult gamma
globulin can modify both natural and live virus vaccine induced measles.
This observation suggests that antibody invoked by inactivated vaccine might
modify the reaction to live vaccine."
If this be true, then it would follow that inasmuch as the antibodies in gamma globulin
are similar to, if not identical with, those produced by the active immunization of
vaccine, the same type of failure might be anticipated from vaccine as was experienced
with gamma globulin (the occurrence of measles encephalitis in patients whose measles
had been modified by gamma globulin). This would present a gloomy outlook for
measles vaccine were it not for the encouraging explanation for the failure of gamma
globulin to protect the patient from encephalitis offered by Koprowski4 in which he
envisions the invasion of the central nervous system by the virus during the short
period between exposure and the administration of the gamma globulin. In contrast,
the protection afforded by vaccine will be present at the time of exposure and should
prevent the virus from invading the central nervous system. The remaining probability
of such invasion would be in those children who had not achieved complete protection
from the vaccine, the 18 per cent pointed out by Fulginiti and Kempe. 3 However, of
this group two thirds ( 12 per cent) did get partial protection in that they developed
a modified measles. This immediately ra.ises the question as to whether this amount
of protection is sufficient to prevent nervous system invasion by the virus. These
considerations are bound to influence the choice of vaccine to be used, for the
expectation of protection against measles encephalitis will be greatest with that vaccine
which is shown to give the highest percentage of prevention rather than just modification,
at least until such time as modification is known to be equally effective in preventing
the entrance of virus into the brain. For the present, the combination of two injections
of inactivated virus followed by one of live seems to be preferred.
Of the two foregoing factors, 1) presence of antibody in the blood at the time
of exposure, and 2) effectiveness of the immunity from the three different methods of
vaccination employed, it is important to know the part each plays in the p�vention
of measles encephalitis. Clini�al trial in a large series of vaccinees will probably
give the answer, but it must be remembered that measles encephalitis is a relatively
rare condition and it may require several years to produce sufficient data on which
valid conclusions can be drawn. We recognize that other factors such as familial
predisposition, previous central nervous system damage, possible differences in the
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neurotropic propensities of different measles viral strains and others have been
suggested as entering into the pathogenesis of measles encephalitis.
It would be interesting to know if encephalitis bas ever occurred in a child who
had been exposed to measles and received gamma globulin but did not develop
clinical measles in any form. We are not aware of any such cases being reported
but if timing or "hyperergy", as interpreted by Koprowski4 is involved in measles
encephalitis, they are certain to occur since clinical signs of measles may well be
completely masked by gamma globulin given after invasion of the central nervous
system.
The behavior of the superficial reflexes ( abdominal and cremasteric) in case
P.G. is interesting, particularly since a similar pattern was noted in another boy with
measles encephalitis whose measles was not modified with gamma globulin but did
occur in the same epidemic. In his case the reflexes were examined critically because
P.O. had alerted us to the difference between the deep and superficial reflexes. His
deep reflexes were present normally at a time when the abdominal and cremasteric
were absent. It was also noted that when the patient improved clinically, the abdominal
and cremasteric reflexes began to return. At first they were weak and easily fatigued,
that is, after being elicited two or three times they would disappear for two to three
hours, after which time the same reaction could be obtained. At the time of his last
follow-up visit (seven weeks after the onset of the encephalitis) he seemed completely
recovered and the superficial and deep reflexes were normal.

SUMMARY

Two additional cases of measles encephalitis, after a modifying dose of gamma
globulin, are being reported. A valid explanation of this undesired occurrence seems
to us to be embodied in Koprowski's3 interpretation of "hyperergy," the possibility of
central nervous system invasion by virus, between exposure and administration of the
gamma globulin. This early invasion should not occur in successful measles vaccination
inasmuch as the protection is present at the time of exposure.
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